EPHA2 and urothelial carcinoma: To expand our analysis of EphA2 prevalence, EphA2 expression was assessed in a tissue microarray with 177 urothelial carcinoma samples, including 48 non-muscle invasive and 129 muscle invasive bladder cancer of various stages.